Can Complementary Prime-Boost Immunization Strategies Be an Alternative and Promising Vaccine Approach Against Dengue Virus?
出版年份 2019 全文链接
标题
Can Complementary Prime-Boost Immunization Strategies Be an Alternative and Promising Vaccine Approach Against Dengue Virus?
作者
关键词
-
出版物
Frontiers in Immunology
Volume 10, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2019-08-27
DOI
10.3389/fimmu.2019.01956
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Dengue
- (2019) Annelies Wilder-Smith et al. LANCET
- A heterologous prime-boost strategy for immunization against Dengue virus combining the Tetra DIIIC subunit vaccine candidate with the TV005 live-attenuated tetravalent vaccine
- (2019) Iris Valdés et al. JOURNAL OF GENERAL VIROLOGY
- Effective Dengue Vaccines: A Pipe Dream?
- (2019) Lázaro Gil et al. VIRAL IMMUNOLOGY
- Effect of Dengue Serostatus on Dengue Vaccine Safety and Efficacy
- (2018) Saranya Sridhar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical development and regulatory points for consideration for second-generation live attenuated dengue vaccines
- (2018) Kirsten S. Vannice et al. VACCINE
- Deliberations of the Strategic Advisory Group of Experts on Immunization on the use of CYD-TDV dengue vaccine
- (2018) Annelies Wilder-Smith et al. LANCET INFECTIOUS DISEASES
- The Profile of T Cell Responses in Bacille Calmette–Guérin-Primed Mice Boosted by a Novel Sendai Virus Vectored Anti-Tuberculosis Vaccine
- (2018) Zhidong Hu et al. Frontiers in Immunology
- A recombinant live attenuated tetravalent vaccine for the prevention of dengue
- (2017) Bruno Guy et al. Expert Review of Vaccines
- Advancing dengue vaccine development
- (2017) Mark B. Feinberg et al. SCIENCE
- Immune correlates of protection for dengue: State of the art and research agenda
- (2017) Leah C. Katzelnick et al. VACCINE
- Which Dengue Vaccine Approach Is the Most Promising, and Should We Be Concerned about Enhanced Disease after Vaccination?
- (2017) Bruno Guy Cold Spring Harbor Perspectives in Biology
- Which Dengue Vaccine Approach Is the Most Promising, and Should We Be Concerned about Enhanced Disease after Vaccination?
- (2017) Gavin Screaton et al. Cold Spring Harbor Perspectives in Biology
- Progress in HIV vaccine development
- (2017) Denise C. Hsu et al. Human Vaccines & Immunotherapeutics
- New developments in an old strategy: heterologous vector primes and envelope protein boosts in HIV vaccine design
- (2016) Thomas Musich et al. Expert Review of Vaccines
- A recombinant, chimeric tetravalent dengue vaccine candidate based on a dengue virus serotype 2 backbone
- (2016) Jorge E. Osorio et al. Expert Review of Vaccines
- A Tetravalent Formulation Based on Recombinant Nucleocapsid-like Particles from Dengue Viruses Induces a Functional Immune Response in Mice and Monkeys
- (2016) Lázaro Gil et al. JOURNAL OF IMMUNOLOGY
- A 12-Month–Interval Dosing Study in Adults Indicates That a Single Dose of the National Institute of Allergy and Infectious Diseases Tetravalent Dengue Vaccine Induces a Robust Neutralizing Antibody Response
- (2016) Anna P. Durbin et al. JOURNAL OF INFECTIOUS DISEASES
- HLA-DRB1 Alleles Are Associated With Different Magnitudes of Dengue Virus–Specific CD4+T-Cell Responses
- (2016) Daniela Weiskopf et al. JOURNAL OF INFECTIOUS DISEASES
- Evidence-based risk assessment and communication: a new global dengue-risk map for travellers and clinicians#
- (2016) Emily S. Jentes et al. JOURNAL OF TRAVEL MEDICINE
- Recombinant BCG prime and PPE protein boost provides potent protection against acute Mycobacterium tuberculosis infection in mice
- (2016) Enzhuo Yang et al. MICROBIAL PATHOGENESIS
- Evaluation of protection induced by a dengue virus serotype 2 envelope domain III protein scaffold/DNA vaccine in non-human primates
- (2016) Sean P. McBurney et al. VACCINE
- Prime-boost vaccine strategy against viral infections: Mechanisms and benefits
- (2016) Kimia Kardani et al. VACCINE
- Challenges to the Design of Clinical Trials for Live-Attenuated Tetravalent Dengue Vaccines
- (2016) Philip K. Russell et al. PLoS Neglected Tropical Diseases
- Incomplete Protection against Dengue Virus Type 2 Re-infection in Peru
- (2016) Brett M. Forshey et al. PLoS Neglected Tropical Diseases
- Could an experimental dengue virus infection fail to induce solid immunity against homologous viral challenge in non-human primates?
- (2015) Iris Valdés et al. ARCHIVES OF VIROLOGY
- Development of TV003/TV005, a single dose, highly immunogenic live attenuated dengue vaccine; what makes this vaccine different from the Sanofi-Pasteur CYD™ vaccine?
- (2015) Stephen S. Whitehead Expert Review of Vaccines
- Robust and Balanced Immune Responses to All 4 Dengue Virus Serotypes Following Administration of a Single Dose of a Live Attenuated Tetravalent Dengue Vaccine to Healthy, Flavivirus-Naive Adults
- (2015) Beth D. Kirkpatrick et al. JOURNAL OF INFECTIOUS DISEASES
- CD8+T Cells Can Mediate Short-Term Protection against Heterotypic Dengue Virus Reinfection in Mice
- (2015) Raphaël M. Zellweger et al. JOURNAL OF VIROLOGY
- VLP production in Leishmania tarentolae : A novel expression system for purification and assembly of HPV16 L1
- (2015) Azam Bolhassani et al. PROTEIN EXPRESSION AND PURIFICATION
- HSP60 – a double edge sword in autoimmunity
- (2015) Dorit Landstein et al. Oncotarget
- Generation and characterization of potential dengue vaccine candidates based on domain III of the envelope protein and the capsid protein of the four serotypes of dengue virus
- (2014) Edith Suzarte et al. ARCHIVES OF VIROLOGY
- Vaccines for the 21st century
- (2014) I. Delany et al. EMBO Molecular Medicine
- CD8+T Cells Prevent Antigen-Induced Antibody-Dependent Enhancement of Dengue Disease in Mice
- (2014) Raphaël M. Zellweger et al. JOURNAL OF IMMUNOLOGY
- Valuing vaccination
- (2014) T. Barnighausen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Enhanced cell immune responses to hepatitis c virus core by novel heterologous DNA prime/lambda nanoparticles boost in mice
- (2014) Atefeh Saeedi et al. VIRUS GENES
- Complex Correlates of Protection After Vaccination
- (2013) S. A. Plotkin CLINICAL INFECTIOUS DISEASES
- Recent advances in antibody-inducing poxviral and adenoviral vectored vaccine delivery platforms for difficult disease targets
- (2013) Simone C de Cassan et al. Expert Review of Vaccines
- A Heterologous Prime/Boost Vaccination Strategy Enhances the Immunogenicity of Therapeutic Vaccines for Hepatitis C Virus
- (2013) Anne Fournillier et al. JOURNAL OF INFECTIOUS DISEASES
- A Single Dose of Any of Four Different Live Attenuated Tetravalent Dengue Vaccines Is Safe and Immunogenic in Flavivirus-naive Adults: A Randomized, Double-blind Clinical Trial
- (2013) Anna P. Durbin et al. JOURNAL OF INFECTIOUS DISEASES
- The global distribution and burden of dengue
- (2013) Samir Bhatt et al. NATURE
- The Synergistic Effect of Combined Immunization with a DNA Vaccine and Chimeric Yellow Fever/Dengue Virus Leads to Strong Protection against Dengue
- (2013) Adriana S. Azevedo et al. PLoS One
- Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells
- (2013) D. Weiskopf et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Helicobacter pylori -glutamyl transpeptidase and vacuolating cytotoxin promote gastric persistence and immune tolerance
- (2013) M. Oertli et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identifying protective dengue vaccines: Guide to mastering an empirical process
- (2013) Scott B. Halstead VACCINE
- Role of Humoral versus Cellular Responses Induced by a Protective Dengue Vaccine Candidate
- (2013) Raphaël M. Zellweger et al. PLoS Pathogens
- Nomenclature for Immune Correlates of Protection After Vaccination
- (2012) S. A. Plotkin et al. CLINICAL INFECTIOUS DISEASES
- Prime–boost approaches to tuberculosis vaccine development
- (2012) Neha Dalmia et al. Expert Review of Vaccines
- Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial
- (2012) Arunee Sabchareon et al. LANCET
- Priming Effect of Dengue and Yellow Fever Vaccination on the Immunogenicity, Infectivity, and Safety of a Tetravalent Dengue Vaccine in Humans
- (2011) Ming Qiao et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- The Chimeric Protein Domain III-Capsid of Dengue Virus Serotype 2 (DEN-2) Successfully Boosts Neutralizing Antibodies Generated in Monkeys upon Infection with DEN-2
- (2011) Iris Valdés et al. Clinical and Vaccine Immunology
- Emerging Vaccine Informatics
- (2011) Yongqun He et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- The development of vaccines: how the past led to the future
- (2011) Stanley A. Plotkin et al. NATURE REVIEWS MICROBIOLOGY
- Distinct Humoral and Cellular Immunity Induced by Alternating Prime-boost Vaccination Using Plasmid DNA and Live Viral Vector Vaccines Expressing the E Protein of Dengue Virus Type 2
- (2011) Junu A. George et al. Immune Network
- A plasmid encoding parts of the dengue virus E and NS1 proteins induces an immune response in a mouse model
- (2010) Gabriela Mellado-Sánchez et al. ARCHIVES OF VIROLOGY
- Immunologic Basis of Vaccine Vectors
- (2010) Margaret A. Liu IMMUNITY
- DNA Vaccines: Developing New Strategies against Cancer
- (2010) Daniela Fioretti et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- CD4+ T Cells Are Not Required for the Induction of Dengue Virus-Specific CD8+ T Cell or Antibody Responses but Contribute to Protection after Vaccination
- (2010) L. E. Yauch et al. JOURNAL OF IMMUNOLOGY
- Heterotypic Dengue Infection with Live Attenuated Monotypic Dengue Virus Vaccines: Implications for Vaccination of Populations in Areas Where Dengue Is Endemic
- (2010) Anna P. Durbin et al. JOURNAL OF INFECTIOUS DISEASES
- Heterologous prime–boost vaccination
- (2009) Shan Lu CURRENT OPINION IN IMMUNOLOGY
- Heterologous prime-boost strategy in non-human primates combining the infective dengue virus and a recombinant protein in a formulation suitable for human use
- (2009) Iris Valdés et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Immunogenicity of sanofi pasteur tetravalent dengue vaccine
- (2009) Bruno Guy JOURNAL OF CLINICAL VIROLOGY
- A Protective Role for Dengue Virus-Specific CD8+ T Cells
- (2009) L. E. Yauch et al. JOURNAL OF IMMUNOLOGY
- Protection against dengue virus by non-replicating and live attenuated vaccines used together in a prime boost vaccination strategy
- (2009) Monika Simmons et al. VIROLOGY
- Cell-mediated immunity induced by chimeric tetravalent dengue vaccine in naive or flavivirus-primed subjects
- (2008) Bruno Guy et al. VACCINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More